TETRALOGIC PHARMACEUTICALS CORP Research and Development Expense
TETRALOGIC PHARMACEUTICALS CORP reported Research and Development Expense of $1.50 million for the 3-month period ending 2016-06-30, per its 10-Q filed 2016-08-11.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2016-08-11
- TETRALOGIC PHARMACEUTICALS CORP research and development expense for the quarter ending 2016-06-30 was $1.50M, a 80.56% decline year-over-year.
- TETRALOGIC PHARMACEUTICALS CORP research and development expense for the quarter ending 2016-03-31 was $3.30M, a 48.78% decline year-over-year.
- TETRALOGIC PHARMACEUTICALS CORP research and development expense for the quarter ending 2015-12-31 was $7.15M, a 12.91% increase year-over-year.
- TETRALOGIC PHARMACEUTICALS CORP research and development expense for the quarter ending 2015-09-30 was $6.10M, a 2.15% increase year-over-year.
- TETRALOGIC PHARMACEUTICALS CORP research and development expense for fiscal 2015 was $27.40M, a 35.07% increase from fiscal 2014.
- TETRALOGIC PHARMACEUTICALS CORP research and development expense for fiscal 2014 was $20.29M, a 113.02% increase from fiscal 2013.
- TETRALOGIC PHARMACEUTICALS CORP research and development expense for fiscal 2013 was $9.52M.
| Period end | Research and Development Expense 3 month | Research and Development Expense 6 month | Research and Development Expense 9 month | Research and Development Expense 12 month | Research and Development Expense 126 month |
|---|---|---|---|---|---|
| 2016-06-30 | $1.50M 10-Q · filed 2016-08-11 | $4.80M 10-Q · filed 2016-08-11 | $11.95M derived: sum of 3 quarters · filed 2016-08-11 | $18.05M derived: sum of 4 quarters · filed 2016-08-11 | |
| 2016-03-31 | $3.30M 10-Q · filed 2016-05-04 | $10.45M derived: sum of 2 quarters · filed 2016-05-04 | $16.55M derived: sum of 3 quarters · filed 2016-05-04 | $24.26M derived: sum of 4 quarters · filed 2016-08-11 | |
| 2015-12-31 | $7.15M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-16 | $13.25M derived: sum of 2 quarters · filed 2016-03-16 | $20.96M derived: sum of 3 quarters · filed 2016-08-11 | $27.40M 10-K · filed 2016-03-16 | |
| 2015-09-30 | $6.10M 10-Q · filed 2015-11-04 | $13.81M derived: sum of 2 quarters · filed 2016-08-11 | $20.25M 10-Q · filed 2015-11-04 | $26.58M derived: sum of 4 quarters · filed 2016-08-11 | |
| 2015-06-30 | $7.71M 10-Q · filed 2016-08-11 | $14.16M 10-Q · filed 2016-08-11 | $20.49M derived: sum of 3 quarters · filed 2016-08-11 | $26.46M derived: sum of 4 quarters · filed 2016-08-11 | |
| 2015-03-31 | $6.45M 10-Q · filed 2016-05-04 | $12.78M derived: sum of 2 quarters · filed 2016-05-04 | $18.75M derived: sum of 3 quarters · filed 2016-05-04 | $23.61M derived: sum of 4 quarters · filed 2016-05-04 | |
| 2014-12-31 | $6.33M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-16 | $12.30M derived: sum of 2 quarters · filed 2016-03-16 | $17.16M derived: sum of 3 quarters · filed 2016-03-16 | $20.29M 10-K · filed 2016-03-16 | |
| 2014-09-30 | $5.97M 10-Q · filed 2015-11-04 | $10.83M derived: sum of 2 quarters · filed 2015-11-04 | $13.96M 10-Q · filed 2015-11-04 | $17.04M derived: sum of 4 quarters · filed 2015-11-04 | |
| 2014-06-30 | $4.86M 10-Q · filed 2015-08-05 | $7.99M 10-Q · filed 2015-08-05 | $11.07M derived: sum of 3 quarters · filed 2015-08-05 | $13.22M derived: sum of 4 quarters · filed 2015-08-05 | |
| 2014-03-31 | $3.12M 10-Q · filed 2015-05-14 | $6.21M derived: sum of 2 quarters · filed 2015-05-14 | $8.36M derived: sum of 3 quarters · filed 2015-05-14 | $10.40M derived: sum of 4 quarters · filed 2015-05-14 | $76.40M 10-Q · filed 2014-05-08 |
| 2013-12-31 | $3.08M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-26 | $5.23M derived: sum of 2 quarters · filed 2015-02-26 | $7.28M derived: sum of 3 quarters · filed 2015-02-26 | $9.52M 10-K · filed 2015-02-26 | |
| 2013-09-30 | $2.15M 10-Q · filed 2014-11-05 | $4.20M derived: sum of 2 quarters · filed 2014-11-05 | $6.44M 10-Q · filed 2014-11-05 | ||
| 2013-06-30 | $2.05M 10-Q · filed 2014-08-05 | $4.29M 10-Q · filed 2014-08-05 | |||
| 2013-03-31 | $2.24M 10-Q · filed 2014-05-08 |